US panel backs first-of-a-kind COVID-19 pill from Merck
Allergic conditions linked to lower COVID-19 infection risk
30 November 2021Sequencing of bone marrow DNA may predict leukemia relapse after CAR-T therapy with sufficient time to intervene
1 December 2021US panel backs first-of-a-kind COVID-19 pill from Merck
A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.
